Xilio Therapeutics, Inc.XLONASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank67
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-56.54M
Near historical average
Percentile
P67
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-60.49M
Historical baseline
PeriodValueYoY Change
TTM$-56.54M+2.5%
2024$-58.00M+24.9%
2023$-77.23M+11.5%
2022$-87.30M-18.5%
2021$-73.70M-37.6%
2020$-53.55M-213.7%
2019$-17.07M-